ARCHITECT® HIV Ag/Ab Combo assay: Correlation of HIV-1 p24 antigen sensitivity and RNA viral load using genetically diverse virus isolates

Journal of Clinical Virology

Volumn 57, Issue 2, 2013, Pages 169-172

  Brennan, Catherine A ^a   Yamaguchi, Julie ^a   Vallari, Ana ^a   Swanson, Priscilla ^a   Hackett Jr, John R ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Acute HIV infection; HIV Ag Ab combination assay; HIV 1 viral load; P24 antigen

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS RNA;

ACUTE DISEASE; ANTIBODY RESPONSE; ARTICLE; CELL CULTURE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN ANTIBODY COMBINATION ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SENSITIVITY ANALYSIS; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

ACUTE DISEASE; FEMALE; GENETIC VARIATION; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; MALE; REAGENT KITS, DIAGNOSTIC; RECOMBINATION, GENETIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84876961489     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.01.017     Document Type: Article

References (26)

1. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
2. Marks G., Crepaz N., Janssen R.S. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006, 20:1447-1450.
3. Brenner B.G., Roger M., Routy J.P., Moisi D., Ntemgwa M., Matte C., et al. High rates of forward transmission events after acute/early HIV-1 infection. J Infect Dis 2007, 195:951-959.
4. Pilcher C.D., Joaki G., Hoffman I.F., Martinson F.E., Mapanje C., Stewart P.W., et al. Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007, 21:1723-1730.
5. Hollingsworth T.D., Anderson R.M., Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008, 198:687-693.
6. Schacker T., Collier A.C., Hughes J., Shea T., Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996, 125:257-264.
7. Weintrob A.C., Giner J., Menezes P., Patrick E., Benjamin D.K., Lennox J., et al. Infrequent diagnosis of primary human immunodeficiency virus infection. Arch Intern Med 2003, 163:2097-2100.
8. Ly T.D., Ebel A., Faucher V., Fihman V., Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?. J Virol Methods 2007, 143:86-94.
9. Andersson S., Asjö B., Jenum P.A., Manner I., Njölstad G., Ragnhildstveit E., et al. Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab 2004, 50:409-413.
10. McElborough D. Importance of using an HIV Ag/Ab combined assay in a UK population at high risk of aquiring HIV infection. Commun Dis Public Health 2004, 7:312-314.
11. Cunningham P., Downie J., O'Loughlin P., Evans S., Black J. Incremental detection of HIV infections by the HIV antigen/antibody combination assays: an Australian experience. J Med Virol 2007, 79:S16-S22.
12. Eshleman S.H., Khaki L., Laeyendecker O., Piwowar-Manning E., Johnson-Lewis L., Husnik M., et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr 2009, 52:121-124.
13. Pandori M.W., Hackett J., Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009, 47:2639-2642.
14. Stekler J.D., Swenson P.D., Coombs R.W., Dragavon J., Thomas K.K., Brennan C.A., et al. HIV testing in a high-incidence population: is antibody testing alone good enough?. Clin Infect Dis 2009, 49:444-453.
15. Patel P., Mackellar D., Simmons P., Uniyal A., Gallagher K., Bennett B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170:66-74.
16. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 51:S17-S22.
17. Kallis M.Y., Anderson C.M., Morris S.R., Smith D.M., Little S.J. Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol 2012, 50:1874-1878.
18. Ly T.D., Plantier J.C., Leballais L., Gonzalo S., Lemée V., Laperche S. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection. J Clin Virol 2012, 55:121-127.
19. Swanson P., Devare S.G., Hackett J. Molecular characterization of 39 HIV isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 2003, 19:625-629.
20. Swanson P., Huang S., Abravaya K., de Mendoza C., Soriano V., Devare S.G., et al. Evaluation of performance across the dynamic range of the Abbott RealTime™ HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. J Virol Methods 2007, 141:49-57.
21. Hackett J., Swanson P., West D., Vickstrom R., Devare S.G., Schochetman G., et al. AARCHITECT HIV Ag/Ab combination assay: correlation of HIV-1 p24 antigen sensitivity and RNA viral load. Presented at: 4th International AIDS Society Conference on HIV Pathogenesis and Treatment 2007, abstract # TUPEB020.
22. ® HIV-1/2 Ag/Ab Combo test. J Infect Dis 2012, 205:528-534.
23. Brennan C.A., Yamaguchi J., Devare S.G., Foster G.A., Stramer S.L. Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007. Transfusion (Paris) 2010, 50:2707-2712.
24. Wheeler W., Mahle K., Bodnar U., Kline R., Hall I., McKenna M., et al. Antiretroviral drug-resistance mutations and subtypes in drug-naive persons newly diagnosed with HIV infection, US March 2003-October 2006. Presented at: 14th Conference on Retroviruses and Opportunistic Infections 2007, abstract # 648.
25. Pyne M, Hackett Jr J, Holzmayer V, Hillyard DR. Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States. Submitted for publication.
26. Semaille C., Barin F., Cazein F., Pillonel J., Lot F., Brand D., et al. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses; experience after 2 years in France. J Infect Dis 2007, 196:377-383.